2019
DOI: 10.1021/acs.nanolett.8b04763
|View full text |Cite
|
Sign up to set email alerts
|

Tumor Microenvironment-Responsive Cu2(OH)PO4 Nanocrystals for Selective and Controllable Radiosentization via the X-ray-Triggered Fenton-like Reaction

Abstract: Traditional radiotherapy can induce injury to the normal tissue around the tumor, so the development of novel radiosensitizer with high selectivity and controllability that can lead to more effective and reliable radiotherapy is highly desirable. Herein, a new smart radiosensitizer based on Cu 2 (OH)PO 4 nanocrystals that can simultaneously respond to endogenous stimulus (H 2 O 2 ) and exogenous stimulus (X-ray) is reported. First, Cu 2 (OH)PO 4 nanocrystals can generate Cu I sites under X-ray irradiation thro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
96
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 150 publications
(100 citation statements)
references
References 49 publications
0
96
0
Order By: Relevance
“…[116] In addition to the most explored tumor microenvironmentactivated Fenton reaction for tumor-oxidative therapy by Cu-involved nanocatalysts, the external X-ray as the stimulus was employed for triggering Cu-based Fenton reaction and subsequent tumor-oxidative therapy. [94] In detail, copper hydroxyphosphate nanocatalysts (Cu 2 (OH)PO 4 NC) were initially synthesized followed by further surface mediation with poly(acrylic acid) sodium (PAAS). The exogenous X-ray irradiation converted Cu II sites into Cu I sites, which was more catalytically active in triggering Fenton reaction (Figure 11a).…”
Section: Cu-involved Nanocatalysts For Catalytic Medicinementioning
confidence: 99%
See 1 more Smart Citation
“…[116] In addition to the most explored tumor microenvironmentactivated Fenton reaction for tumor-oxidative therapy by Cu-involved nanocatalysts, the external X-ray as the stimulus was employed for triggering Cu-based Fenton reaction and subsequent tumor-oxidative therapy. [94] In detail, copper hydroxyphosphate nanocatalysts (Cu 2 (OH)PO 4 NC) were initially synthesized followed by further surface mediation with poly(acrylic acid) sodium (PAAS). The exogenous X-ray irradiation converted Cu II sites into Cu I sites, which was more catalytically active in triggering Fenton reaction (Figure 11a).…”
Section: Cu-involved Nanocatalysts For Catalytic Medicinementioning
confidence: 99%
“…In addition, the change of reaction condition (e.g., elevating local temperature) or rational design of synergistic therapy (e.g., PDT/CDT, PTT/CDT, www.advancedsciencenews.com www.advancedscience.com Reproduced with permission. [94] Copyright 2019, American Chemical Society.…”
Section: Cu-involved Nanocatalysts For Catalytic Medicinementioning
confidence: 99%
“…Of these, one of the most applied approaches to reverse the radioresistance of hypoxic tumors is to employ O 2 -elevated nanomaterials to directly harness the O 2 level in solid tumors 1921. Besides this, some innovative and simple strategies by employing oxygen-independent nanoradiosensitizers have also been explored for hypoxic-tumor RT 2224. These strategies provide promising opportunities for enhancing the radiotherapeutic efficacy of hypoxic tumors.…”
Section: Introductionmentioning
confidence: 99%
“…The combination of QDs (48 nm) and irradiation induced higher levels of cleaved caspase 3 and apoptosis in H460 cells than did irradiation alone [154]. Cu 2 (OH)PO 4 NPs (5 nm) generated Cu I sites under irradiation, which catalyzed the decomposition of H 2 O 2 into hydroxyl radicals in the tumor microenvironment, resulting in the apoptosis and necrosis of HeLa cells [155]. Cationic nanoscale metal-organic frameworks (nMOFs, <100 nm) containing Hf and Ru elements were targeted to mitochondria, resulting in significant depolarization of the mitochondrial membrane, an increased apoptosis rate, and inhibition of tumor growth in mouse models under irradiation (Figure 4).…”
Section: Nanoradiosensitizers Based On Apoptosismentioning
confidence: 99%